90 related articles for article (PubMed ID: 1543360)
1. [Late phase II study of MST-16 (sobuzoxane) efficacy for malignant lymphoma].
Masaoka T; Kageyama T; Tatsumi N; Akasaka K; Yonezawa T; Sugiyama H; Kitani T; Yasunaga K; Horiuchi A; Nakayama S
Gan To Kagaku Ryoho; 1992 Mar; 19(3):339-47. PubMed ID: 1543360
[TBL] [Abstract][Full Text] [Related]
2. [Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
Yamada K; Ohno R; Oguri T; Kamiya O; Yokomaku S; Kobayashi M; Nishiwaki H; Tanaka M; Inagaki J; Mitomo Y
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2447-52. PubMed ID: 1952964
[TBL] [Abstract][Full Text] [Related]
3. [Early phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
Tominaga N; Teshima H; Hiraoka A; Masaoka T; Ariyoshi Y; Suzuki H; Kimura I; Ohnoshi T; Hayashi K; Arima T
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2441-6. PubMed ID: 1952963
[TBL] [Abstract][Full Text] [Related]
4. [Early phase II study of MST-16 (sobuzoxane) for breast cancer].
Tominaga T; Shimozuma K; Hasegawa K; Hayashibara K; Nakahiro K; Nakao I; Katayama K; Fukuda M; Majima H; Aoyama H
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1009-15. PubMed ID: 8210250
[TBL] [Abstract][Full Text] [Related]
5. [Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)].
Taguchi T; Ohta K; Hotta T; Shirakawa S; Masaoka T; Kimura I
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1263-71. PubMed ID: 9279345
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of KRN8602 (MX2) for malignant lymphoma].
Okabe K; Sampi K; Kuraishi Y; Takemoto Y; Tamura K; Ogawa M
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1001-6. PubMed ID: 9644314
[TBL] [Abstract][Full Text] [Related]
7. [Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
Nakayama S; Yabe H; Nagai K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2179-82. PubMed ID: 1888191
[No Abstract] [Full Text] [Related]
8. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
Masaoka T; Ogawa M; Inoue K; Sanpi K; Kuraishi Y; Toki H; Tamura K; Takagi T; Shibata A; Hirano M; Ezaki K; Shirakawa S; Matsuda T; Kimura I
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
[TBL] [Abstract][Full Text] [Related]
9. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
Kimura K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
[TBL] [Abstract][Full Text] [Related]
10. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].
Tagawa S; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
Gan No Rinsho; 1987 Jan; 33(1):1-7. PubMed ID: 3469424
[TBL] [Abstract][Full Text] [Related]
12. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of idarubicin on malignant lymphoma].
Urabe A; Ohno R; Kuraishi Y; Masaoka T; Ohashi Y; Ogawa M
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1275-82. PubMed ID: 10478180
[TBL] [Abstract][Full Text] [Related]
14. [Phase I study of MST-16].
Furue H; Niitani H; Nakao I; Hoshino A; Hasegawa K; Tsukagoshi S; Fujita H
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1287-94. PubMed ID: 2369134
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
Oguro M; Takagi T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):508-15. PubMed ID: 6764108
[TBL] [Abstract][Full Text] [Related]
16. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
17. [A novel antitumor agent, sobuzoxane (MST-16)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1089-97. PubMed ID: 8002628
[TBL] [Abstract][Full Text] [Related]
18. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
Furue H; Machida T; Masaoka T; Ikeda S
Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
[TBL] [Abstract][Full Text] [Related]
19. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
[TBL] [Abstract][Full Text] [Related]
20. [Etoposide 21 therapy for malignant lymphoma].
Masaoka T
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1936-40. PubMed ID: 8978801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
